204 related articles for article (PubMed ID: 30015921)
1. Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix.
Shin SJ; Kim J; Lee S; Baek J; Lee JE; Cho C; Ha E
Int J Mol Med; 2018 Oct; 42(4):1857-1864. PubMed ID: 30015921
[TBL] [Abstract][Full Text] [Related]
2. Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.
Cox J; Malik M; Britten J; Lewis T; Catherino WH
Reprod Sci; 2018 Feb; 25(2):198-206. PubMed ID: 28929861
[TBL] [Abstract][Full Text] [Related]
3. Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms.
Lewis TD; Malik M; Britten J; Parikh T; Cox J; Catherino WH
Fertil Steril; 2019 Apr; 111(4):806-815.e1. PubMed ID: 30871768
[TBL] [Abstract][Full Text] [Related]
4. Ulipristal acetate modulates the expression and functions of activin a in leiomyoma cells.
Ciarmela P; Carrarelli P; Islam MS; Janjusevic M; Zupi E; Tosti C; Castellucci M; Petraglia F
Reprod Sci; 2014 Sep; 21(9):1120-5. PubMed ID: 25001022
[TBL] [Abstract][Full Text] [Related]
5. Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study.
Del Bello B; Marcolongo P; Ciarmela P; Sorbi F; Petraglia F; Luisi S; Maellaro E
Fertil Steril; 2019 Dec; 112(6):1150-1159. PubMed ID: 31843092
[TBL] [Abstract][Full Text] [Related]
6. The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating Uterine Leiomyoma Growth.
Tinelli A; Kosmas IP; Mynbaev OA; Malvasi A; Sparic R; Vergara D
Curr Pharm Des; 2020; 26(3):310-317. PubMed ID: 31987017
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment.
Courtoy GE; Henriet P; Marbaix E; de Codt M; Luyckx M; Donnez J; Dolmans MM
J Clin Endocrinol Metab; 2018 Apr; 103(4):1566-1573. PubMed ID: 29408988
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids.
Ferrero S; Vellone VG; Barra F
Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):107-116. PubMed ID: 29250979
[TBL] [Abstract][Full Text] [Related]
9. Ulipristal Acetate Mediates Decreased Proteoglycan Expression Through Regulation of Nuclear Factor of Activated T-Cells (NFAT5).
Britten JL; Malik M; Lewis TD; Catherino WH
Reprod Sci; 2019 Feb; 26(2):184-197. PubMed ID: 30567472
[TBL] [Abstract][Full Text] [Related]
10. In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment.
Courtoy GE; Donnez J; Marbaix E; Dolmans MM
Fertil Steril; 2015 Aug; 104(2):426-34.e1. PubMed ID: 26003270
[TBL] [Abstract][Full Text] [Related]
11. 1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids.
Ali M; Shahin SM; Sabri NA; Al-Hendy A; Yang Q
Reprod Sci; 2019 Jun; 26(6):812-828. PubMed ID: 30514160
[TBL] [Abstract][Full Text] [Related]
12. Proteins involved in oxidative stress in leiomyoma tissues treated with ulipristal acetate.
Ura B; Monasta L; De Spelorzi YCC; Arrigoni G; Franchin C; Biffi S; Aloisio M; Gaita B; Licastro D; Athanasakis E; Scrimin F; Stabile G; Romano F; Di Lorenzo G; Ricci G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179092
[TBL] [Abstract][Full Text] [Related]
13. Gene expression changes in uterine myomas in response to ulipristal acetate treatment.
Courtoy GE; Donnez J; Ambroise J; Arriagada P; Luyckx M; Marbaix E; Dolmans MM
Reprod Biomed Online; 2018 Aug; 37(2):224-233. PubMed ID: 29807764
[TBL] [Abstract][Full Text] [Related]
14. Ulipristal acetate for uterine fibroid-related symptoms.
Puchar A; Luton D; Koskas M
Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
[TBL] [Abstract][Full Text] [Related]
15. Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids.
Ciebiera M; Włodarczyk M; Wrzosek M; Słabuszewska-Jóźwiak A; Nowicka G; Jakiel G
Fertil Steril; 2018 Mar; 109(3):501-507.e2. PubMed ID: 29525690
[TBL] [Abstract][Full Text] [Related]
16. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
Yoshida S; Ohara N; Xu Q; Chen W; Wang J; Nakabayashi K; Sasaki H; Morikawa A; Maruo T
Semin Reprod Med; 2010 May; 28(3):260-73. PubMed ID: 20414849
[TBL] [Abstract][Full Text] [Related]
17. [The molecular mechanisms and morphological manifestations of leiomyoma reduction induced by selective progesterone receptor modulators].
Demura TA; Revazova ZV; Kogan EA; Adamyan LV
Arkh Patol; 2017; 79(3):19-26. PubMed ID: 28631712
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Xu Q; Ohara N; Liu J; Amano M; Sitruk-Ware R; Yoshida S; Maruo T
Mol Hum Reprod; 2008 Mar; 14(3):181-91. PubMed ID: 18216291
[TBL] [Abstract][Full Text] [Related]
19. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
20. Steroid hormones and hormone antagonists regulate the neural marker neurotrimin in uterine leiomyoma.
Parikh TP; Malik M; Britten J; Aly JM; Pilgrim J; Catherino WH
Fertil Steril; 2020 Jan; 113(1):176-186. PubMed ID: 32033718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]